Free Trial
Ends Tomorrow! Last Chance to Get MarketBeat All Access at $149
  • 0Days
  • 0Hours
  • 0Minutes
  • 0Seconds
Lock In $149
Claim MarketBeat All Access Sale Promotion

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Pfenex Inc. stock logo
PFNX
Pfenex
$12.75
$12.75
$5.26
▼
$14.00
$437.29MN/A503,865 shsN/A
Terns Pharmaceuticals, Inc. stock logo
TERN
Terns Pharmaceuticals
$52.95
$51.03
$2.65
▼
$53.19
$6.12B-0.374.84 million shs6.35 million shs
Target Hospitality Corp. stock logo
TH
Target Hospitality
$14.05
-0.4%
$18.19
$5.97
▼
$21.76
$1.40B1.491.32 million shs540,311 shs
7 Energy Stocks to Buy and Hold Forever Cover

Oil still powers the global economy, but AI is reshaping the energy opportunity. Discover seven stocks spanning traditional energy, infrastructure, and next-generation power.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Pfenex Inc. stock logo
PFNX
Pfenex
0.00%0.00%0.00%0.00%0.00%
Terns Pharmaceuticals, Inc. stock logo
TERN
Terns Pharmaceuticals
0.00%0.00%0.00%0.00%+516.41%
Target Hospitality Corp. stock logo
TH
Target Hospitality
-0.84%-10.01%-26.89%-2.69%+98.17%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Pfenex Inc. stock logo
PFNX
Pfenex
$12.75
$12.75
$5.26
▼
$14.00
$437.29MN/A503,865 shsN/A
Terns Pharmaceuticals, Inc. stock logo
TERN
Terns Pharmaceuticals
$52.95
$51.03
$2.65
▼
$53.19
$6.12B-0.374.84 million shs6.35 million shs
Target Hospitality Corp. stock logo
TH
Target Hospitality
$14.05
-0.4%
$18.19
$5.97
▼
$21.76
$1.40B1.491.32 million shs540,311 shs
7 Energy Stocks to Buy and Hold Forever Cover

Oil still powers the global economy, but AI is reshaping the energy opportunity. Discover seven stocks spanning traditional energy, infrastructure, and next-generation power.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Pfenex Inc. stock logo
PFNX
Pfenex
0.00%0.00%0.00%0.00%0.00%
Terns Pharmaceuticals, Inc. stock logo
TERN
Terns Pharmaceuticals
0.00%0.00%0.00%0.00%+516.41%
Target Hospitality Corp. stock logo
TH
Target Hospitality
-0.84%-10.01%-26.89%-2.69%+98.17%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Pfenex Inc. stock logo
PFNX
Pfenex
0.00
N/AN/AN/A
Terns Pharmaceuticals, Inc. stock logo
TERN
Terns Pharmaceuticals
2.27
Hold$55.144.13% Upside
Target Hospitality Corp. stock logo
TH
Target Hospitality
2.83
Moderate Buy$25.2079.32% Upside

Current Analyst Ratings Breakdown

Latest TH, PFNX, and TERN Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
10/23/2026
Target Hospitality Corp. stock logo
TH
Target Hospitality
DowngradeHold (C-) ➝ Sell (D+)
10/8/2026
Target Hospitality Corp. stock logo
TH
Target Hospitality
UpgradeSell (D+) ➝ Hold (C-)
9/14/2026
Target Hospitality Corp. stock logo
TH
Target Hospitality
Boost Price TargetOverweight$22.00 ➝ $25.00
9/8/2026
Target Hospitality Corp. stock logo
TH
Target Hospitality
Boost Price TargetOutperform$24.00 ➝ $27.00
8/27/2026
Target Hospitality Corp. stock logo
TH
Target Hospitality
Set Price Target$25.00
8/27/2026
Target Hospitality Corp. stock logo
TH
Target Hospitality
Set Price Target$26.00
8/27/2026
Target Hospitality Corp. stock logo
TH
Target Hospitality
Reiterated RatingBuy$23.00
8/21/2026
Target Hospitality Corp. stock logo
TH
Target Hospitality
UpgradeSell (D) ➝ Sell (D+)
8/20/2026
Target Hospitality Corp. stock logo
TH
Target Hospitality
UpgradeHold ➝ Buy$22.00
8/17/2026
Target Hospitality Corp. stock logo
TH
Target Hospitality
Initiated CoverageOverweight$22.00
(Data available from 10/29/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Pfenex Inc. stock logo
PFNX
Pfenex
N/AN/AN/AN/AN/AN/A
Terns Pharmaceuticals, Inc. stock logo
TERN
Terns Pharmaceuticals
N/AN/AN/AN/A$9.70 per shareN/A
Target Hospitality Corp. stock logo
TH
Target Hospitality
$347.37M4.03$0.41 per share34.57$3.90 per share3.60
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Pfenex Inc. stock logo
PFNX
Pfenex
N/AN/AN/AN/AN/AN/AN/AN/AN/A
Terns Pharmaceuticals, Inc. stock logo
TERN
Terns Pharmaceuticals
-$96.21M-$1.03N/AN/AN/AN/A-20.02%-19.37%N/A
Target Hospitality Corp. stock logo
TH
Target Hospitality
-$37.12M-$0.38N/A15.44N/A-10.85%-9.80%-6.65%11/5/2026 (Estimated)

Latest TH, PFNX, and TERN Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/5/2026Q3 2026
Target Hospitality Corp. stock logo
TH
Target Hospitality
-$0.0017N/AN/AN/A$118.35 millionN/A
8/10/2026Q2 2026
Target Hospitality Corp. stock logo
TH
Target Hospitality
-$0.1060-$0.09+$0.0160-$0.09$79.30 million$85.46 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Pfenex Inc. stock logo
PFNX
Pfenex
N/AN/AN/AN/AN/A
Terns Pharmaceuticals, Inc. stock logo
TERN
Terns Pharmaceuticals
N/AN/AN/AN/AN/A
Target Hospitality Corp. stock logo
TH
Target Hospitality
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Pfenex Inc. stock logo
PFNX
Pfenex
N/AN/AN/A
Terns Pharmaceuticals, Inc. stock logo
TERN
Terns Pharmaceuticals
N/A
62.41
62.41
Target Hospitality Corp. stock logo
TH
Target Hospitality
0.11
0.65
0.65

Institutional Ownership

CompanyInstitutional Ownership
Pfenex Inc. stock logo
PFNX
Pfenex
N/A
Terns Pharmaceuticals, Inc. stock logo
TERN
Terns Pharmaceuticals
98.26%
Target Hospitality Corp. stock logo
TH
Target Hospitality
32.40%

Insider Ownership

CompanyInsider Ownership
Pfenex Inc. stock logo
PFNX
Pfenex
N/A
Terns Pharmaceuticals, Inc. stock logo
TERN
Terns Pharmaceuticals
1.50%
Target Hospitality Corp. stock logo
TH
Target Hospitality
3.80%
CompanyEmployeesShares OutstandingFree FloatOptionable
Pfenex Inc. stock logo
PFNX
Pfenex
7134.30 millionN/ANot Optionable
Terns Pharmaceuticals, Inc. stock logo
TERN
Terns Pharmaceuticals
40115.52 million113.79 millionNot Optionable
Target Hospitality Corp. stock logo
TH
Target Hospitality
90299.62 million95.84 millionOptionable

Recent News About These Companies

Is Target Hospitality (TH) Reasonable On Future Cash Flow?
Target Hospitality CEO Archer Buys 13,385 Shares

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Pfenex stock logo

Pfenex NYSEAMERICAN:PFNX

$12.75 0.00 (0.00%)
As of 10/1/2020

Pfenex Inc., a clinical-stage development and licensing biotechnology company, focuses on developing protein therapies for unmet patient needs. Its lead product candidates include PF708, a therapeutic equivalent drug candidate to Forteo (teriparatide) for the treatment of osteoporosis; and novel anthrax vaccine candidates, such as Px563L and RPA563 that have completed Phase Ia clinical study. The company also develops PF582, a biosimilar candidate to Lucentis; PF529, a biosimilar to Neulasta; and hematology/oncology products, including PF743, a recombinant crisantaspase, as well as PF745, a recombinant crisantaspase with half-life extension technology. In addition, it has license and supply agreements for CRM197, a non-toxic mutant of diphtheria toxin. Pfenex Inc. is headquartered in San Diego, California.

Terns Pharmaceuticals stock logo

Terns Pharmaceuticals NASDAQ:TERN

Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule product candidates for the treatment of oncology, metabolic dysfunction-associated steatohepatitis (MASH), and obesity. The company develops TERN-701, an allosteric BCR-ABL tyrosine kinase inhibitor (TKI) that is in phase 1 clinical trial for chronic myeloid leukemia (CML), a form of cancer that starts in bone marrow. It also develops TERN-501, a thyroid hormone receptor beta agonist with enhanced liver distribution and metabolic stability that is in Phase IIa clinical trial for the treatment of MASH; and TERN-601, a small-molecule Glucagon-Like Peptide-1 receptor agonist program that is intended to orally be administered for obesity. The company was incorporated in 2016 and is headquartered in Foster City, California.

Target Hospitality stock logo

Target Hospitality NASDAQ:TH

$14.05 -0.06 (-0.40%)
As of 03:03 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Target Hospitality Corp. operates as a specialty rental and hospitality services company in North America. The company operates through two segments, Hospitality & Facilities Services - South and Government. It owns a network of specialty rental accommodation units. In addition, the company provides catering and food, maintenance, housekeeping, grounds-keeping, security, health and recreation facilities, workforce community management, concierge, and laundry services. It serves the U.S. government contractors and investment grade natural resource development companies. Target Hospitality Corp. was founded in 1978 and is headquartered in The Woodlands, Texas.